For the aripiprazole study group. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. - Keck,PE.; Calabrese,JR.; McQuade,RD.; Carson,WH.; Carlson,BX.; Rollin,LM. (J Clin Psychiatry, 2006)